Freedom Broker maintains Merck & Co at Hold, raises price target to $140 from $125
קריאה של פחות מדקה
Freedom Broker maintained Merck & Co at Hold and raised its price target to $140 from $125, a 12.0% increase.
The price target implies a downside of 5.6% from the Nov 2 close of $148.36.
Recent analyst actions on Merck & Co
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 2 | Cantor Fitzgerald | Maintains | Neutral | $155 |
| Oct 30 | JP Morgan | Maintains | Overweight | $175 |
| Oct 30 | RBC Capital | Maintains | Sector Perform | $140 |
| Oct 30 | Guggenheim | Maintains | Buy | $171 |
| Oct 26 | Barclays | Maintains | Overweight | $180 |
Across the five most recent analyst notes published on Merck & Co over the past 30 days, price targets range from $140 to $180.
Explore more price target data and ratings for Merck & Co on the Forecasts tab, and track all previous and future analyst recommendations in the dedicated News Flow.
Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.
קרא את הכתבה המלאה
קבלת גישה בלתי מוגבלת לעדכוני אנליסטים ולכל שאר הכתבות ב־TradingView.